Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-31

Clinical Trial Update: Colchicine in Chronic Kidney Disease Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating colchicine in patients with chronic kidney disease to assess impact on cardiovascular events, and recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: Hospital General Universitario Gregorio Marañon | Conditions: Chronic Kidney Disease, Cardiovascular Events | Phase 3 | Status: RECRUITING